Photo: Alex Wong/Getty Images

Former FBI Director James Comey told congressional investigators Friday that in the summer of 2016, the FBI opened counterintelligence investigations into four Americans connected to then-candidate Trump to determine if they played a role in Russian interference in the 2016 election.

The big picture: Comey, who testified for seven hours before the House Judiciary and Oversight committees, was unwilling to publicly reveal the identities of the four individuals. But the New York Times reported in May that four Trump associates — Paul Manafort, Michael Flynn, George Papadopoulos and Carter Page — were all investigated by the FBI for potential ties to Russia. Manafort, Flynn and Papadopoulos have since been indicted or pleaded guilty to the special counsel for various crimes.

Go deeper

Updated 49 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment How the pandemic might endMany U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.